RU2010154008A - Эсликарбазепина ацетат и способы его применения - Google Patents
Эсликарбазепина ацетат и способы его применения Download PDFInfo
- Publication number
- RU2010154008A RU2010154008A RU2010154008/15A RU2010154008A RU2010154008A RU 2010154008 A RU2010154008 A RU 2010154008A RU 2010154008/15 A RU2010154008/15 A RU 2010154008/15A RU 2010154008 A RU2010154008 A RU 2010154008A RU 2010154008 A RU2010154008 A RU 2010154008A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- effective amount
- eslicarbazepine
- disorder
- pharmaceutically effective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/PT2005/000006 WO2006121363A1 (en) | 2005-05-06 | 2005-05-06 | Eslicarbazepine acetate and methods of use |
| PTPCT/PT2005/000006 | 2005-05-06 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007145194/15A Division RU2417085C2 (ru) | 2005-05-06 | 2005-05-06 | Эсликарбазепина ацетат и способы его применения |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2010154008A true RU2010154008A (ru) | 2012-07-10 |
Family
ID=35464075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010154008/15A RU2010154008A (ru) | 2005-05-06 | 2010-12-28 | Эсликарбазепина ацетат и способы его применения |
Country Status (8)
| Country | Link |
|---|---|
| EP (6) | EP2386303A1 (enExample) |
| JP (1) | JP2008540405A (enExample) |
| KR (1) | KR101236227B1 (enExample) |
| CN (1) | CN101217959A (enExample) |
| ES (2) | ES2534514T3 (enExample) |
| PT (2) | PT2380573E (enExample) |
| RU (1) | RU2010154008A (enExample) |
| WO (1) | WO2006121363A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| GB0603008D0 (en) * | 2006-02-14 | 2006-03-29 | Portela & Ca Sa | Method |
| GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| US8372431B2 (en) * | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
| RU2012113844A (ru) | 2009-09-10 | 2013-10-20 | Биал-Портела Энд К.А., С.А. | Пероральные суспензионные лекарственные формы ацетата эсликарбазепина |
| TR201008460A1 (tr) * | 2010-10-15 | 2012-05-21 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Eslikarbazepinin saşe formülasyonları. |
| RU2639120C2 (ru) * | 2011-08-26 | 2017-12-19 | Биал-Портела Энд Ка, С.А. | Лечение с использованием ацетата эсликарбазепина или эсликарбазепина |
| US20140243342A1 (en) * | 2013-02-23 | 2014-08-28 | Lixin Zhang | Compositions and methods for prophylaxis and therapy for menieres disease |
| US9814723B2 (en) | 2013-02-23 | 2017-11-14 | Lixin Zhang | Compositions and methods for prophylaxis and therapy for Meniere's disease |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| GB201306095D0 (en) * | 2013-04-04 | 2013-05-22 | Bial Portela & Ca Sa | New treatments |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT101732B (pt) * | 1995-06-30 | 1997-12-31 | Portela & Ca Sa | Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso |
| US6296873B1 (en) | 1997-01-23 | 2001-10-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Zero-order sustained release delivery system for carbamazephine derivatives |
| DE60228988D1 (de) * | 2001-11-12 | 2008-10-30 | Novartis Ag | Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen |
| US7465723B2 (en) * | 2002-08-06 | 2008-12-16 | Novartis | Use of carboxamides for the treatment of tinnitus |
| US20040038874A1 (en) * | 2002-08-22 | 2004-02-26 | Osemwota Omoigui | Method of treatment of persistent pain |
| GB0303615D0 (en) * | 2003-02-17 | 2003-03-19 | Novartis Ag | Use of organic compounds |
| BRPI0407569A (pt) * | 2003-02-17 | 2006-02-14 | Novartis Ag | uso de s-10-hidróxi-10, 11-diidro-carbamazepina para o tratamento de ansiendade e distúrbios bipolares |
| TW200502222A (en) * | 2003-04-02 | 2005-01-16 | Novartis Ag | Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders |
| GB2401605A (en) * | 2003-05-12 | 2004-11-17 | Portela & Ca Sa | Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide and optically enriched mixtures thereof |
| PE20051156A1 (es) * | 2004-03-22 | 2006-02-13 | Novartis Ag | Formulaciones de matriz orales que comprenden licarbazepina |
| AR048672A1 (es) * | 2004-03-22 | 2006-05-17 | Novartis Ag | Tabletas de desintegracion que comprenden licarbazepina |
| BRPI0520258A2 (pt) * | 2005-05-06 | 2009-09-15 | Portela & Ca Sa | uso de uma composição farmacêutica, método para preparar uma composição farmacêutica, e, uso de uma quantidade eficaz de acetato de eslicarbazepina |
-
2005
- 2005-05-06 EP EP11174413A patent/EP2386303A1/en not_active Withdrawn
- 2005-05-06 EP EP11174411A patent/EP2384755A1/en not_active Withdrawn
- 2005-05-06 JP JP2008509964A patent/JP2008540405A/ja active Pending
- 2005-05-06 PT PT111744033T patent/PT2380573E/pt unknown
- 2005-05-06 EP EP05740623A patent/EP1879590A1/en not_active Ceased
- 2005-05-06 ES ES11174403.3T patent/ES2534514T3/es not_active Expired - Lifetime
- 2005-05-06 WO PCT/PT2005/000006 patent/WO2006121363A1/en not_active Ceased
- 2005-05-06 PT PT111744157T patent/PT2380575E/pt unknown
- 2005-05-06 CN CNA2005800509788A patent/CN101217959A/zh active Pending
- 2005-05-06 EP EP11174405A patent/EP2380574A1/en not_active Withdrawn
- 2005-05-06 KR KR1020077028320A patent/KR101236227B1/ko not_active Expired - Lifetime
- 2005-05-06 EP EP11174415.7A patent/EP2380575B1/en not_active Expired - Lifetime
- 2005-05-06 EP EP11174403.3A patent/EP2380573B1/en not_active Expired - Lifetime
- 2005-05-06 ES ES11174415.7T patent/ES2534560T3/es not_active Expired - Lifetime
-
2010
- 2010-12-28 RU RU2010154008/15A patent/RU2010154008A/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080015429A (ko) | 2008-02-19 |
| EP2380575B1 (en) | 2015-02-25 |
| EP2386303A1 (en) | 2011-11-16 |
| CN101217959A (zh) | 2008-07-09 |
| ES2534514T3 (es) | 2015-04-23 |
| EP2384755A1 (en) | 2011-11-09 |
| WO2006121363A1 (en) | 2006-11-16 |
| KR101236227B1 (ko) | 2013-02-21 |
| EP1879590A1 (en) | 2008-01-23 |
| EP2380573B1 (en) | 2015-02-25 |
| PT2380573E (pt) | 2015-06-11 |
| EP2380573A1 (en) | 2011-10-26 |
| PT2380575E (pt) | 2015-06-17 |
| EP2380575A1 (en) | 2011-10-26 |
| JP2008540405A (ja) | 2008-11-20 |
| ES2534560T3 (es) | 2015-04-24 |
| EP2380574A1 (en) | 2011-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010154008A (ru) | Эсликарбазепина ацетат и способы его применения | |
| Yang et al. | SIRT1 plays a neuroprotective role in traumatic brain injury in rats via inhibiting the p38 MAPK pathway | |
| CN114025750A (zh) | 包含神经可塑性作用物质的以非迷幻/致幻觉剂量和制剂给药的组合物和使用方法 | |
| HRP20110570T1 (hr) | Amidi diazabicikloalkana selektivni na podvrstu nikotinskih acetilkolinskih receptora | |
| ES2992838T3 (en) | Treatment of irritability in autism spectrum disorder with cannabidiol | |
| US20150368221A1 (en) | Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors | |
| AR069125A1 (es) | Suspension pediatrica estabilizada de carisbamato | |
| JP2010504950A5 (enExample) | ||
| CA2695519A1 (en) | Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligands | |
| WO2011132435A1 (ja) | 脳機能障害予防・改善用の薬剤及び飲食物 | |
| US20150313903A1 (en) | Methods of treating cognitive impairment associated with neurodegenerative disorders | |
| RU2488397C2 (ru) | Терапевтическое применение эсликарбазепина | |
| US20240082212A1 (en) | Use of mdma for treatment of stress-related disorders | |
| WO2019170115A1 (en) | Pyrrolidineamide derivatives and uses thereof | |
| AU2009219050B2 (en) | Pharmaceutical composition comprising racetam and carnitine and process for its preparation | |
| Kiewert et al. | Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John’s wort | |
| US20080207600A1 (en) | Pharmaceutical Combination for the Treatment of Cns Functional Disorders | |
| CN109414507A (zh) | 用于预防和治疗神经退行性疾病的高度选择性腺苷a3受体亚型激动剂 | |
| RU2007145194A (ru) | Эсликарбазепина ацетат и способы его применения | |
| WO2015153971A1 (en) | Methods of treating sleep disorders associated with neurodegenerative diseases | |
| CN111093772A (zh) | 偏头痛的治疗 | |
| Sharma et al. | Psychopharmacological Treatment of Depression and Anxiety and their Different Drug Delivery Targets | |
| EP2905021B1 (en) | Combination for the prophylaxis and treatment of behavioural, mental and cognitive disorders | |
| Lochana et al. | Carbamazepine and Bipolar Disorder: Pharmacodynamics, Pharmacokinetics, Pharmacogenomics, and Adverse Drug Reactions—A Comprehensive Review | |
| Nair et al. | Resveratrol with an adjunct for improved maintenance of mitochondrial homeostasis and dopamine neuronal rescue in neurodegeneration |